EH
Insider
Elaine J Heron
DirectorElaine J Heron (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Palvella Therapeutics, Inc. (PVLA). Across 1 priced purchase filing, the average 21-session return was -23.3% from execution and -21.8% from disclosure (delay-adjusted; derived). The largest single filing was $300K of PVLA (2,400 sh × $125.00, as filed), executed Feb 27.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-23.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-21.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$300K
shares × price, as filed
Last traded
Feb 27
Filed Mar 2
Median ADV $37.6M across their filed names
Open performance→Volume by month
Buys $300K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
PVLARecent filings
PVLAPURCHASE
Palvella Therapeutics, Inc.
View filing →
$300K2,400 sh × $125.00
Exec Feb 27
Filed Mar 2 · 8:00 AM ET